GlassScriptPhysician profile
Joseph Paul
NPI 1841491305
$588.65
in general payments reported to CMS, 2019-2025
5 companies · $56.14 in 2025
The $56.14 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $171 · 2021: $112 · 2022: $23.25 · 2023: $63.87 · 2025: $56.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $120.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $333.50 | 2019-2020 | |
| Gilead Sciences, INC. | $120.01 | 2023-2025 | |
| Janssen Products, LP | $99.00 | 2021 | |
| Abbott Laboratories | $23.25 | 2022 | |
| Qiagen, LLC | $12.89 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.